AstraZeneca Wins US Approval for Lymphoma Drug - U.S. News & World Report

U.S. News & World Report

AstraZeneca Wins US Approval for Lymphoma Drug U.S. News & World Report U.S. regulators have approved a new treatment for patients with a rare form of non-Hodgkin lymphoma. Oct. 31, 2017, at 2:52 p.m.. AstraZeneca Wins US Approval for Lymphoma Drug. Share. ×. Share on Facebook · Post on Twitter · Post to Reddit. Email. FDA approves new treatment for adults with mantle cell lymphomaFDA.gov FDA Approves Acalabrutinib (Calquence) for Mantle Cell LymphomaMedscape FDA Grants Accelerated Approval to Acalabrutinib for Mantle Cell LymphomaCancer Therapy Advisor Curetoday.com -Healio -Daily Mail -Fox Business all 28 news articles »

from Health - Google News http://ift.tt/2A2JqXs